DDAH1 and cardiovascular disorder: Dimethylarginine dimethylaminohydrolase (DDAH) proteins have significantly advanced our understanding of cardiovascular disease mechanisms (21, 22, 23, 24, 25) and are valued as diagnostic markers (26) and therapeutic targets (27).